PM
Pravat Mohapatra
About Pravat Mohapatra
Data last updated:
Pravat Mohapatra has 5 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Viropana Drug Private Limited and Laetitia Finserv Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Laetitia Finserv Private Limited at ₹0.67 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 07 Apr 2025 | 2021 | ₹0.67 Cr (FY 2022) | Active | |
| Director | 14 Sep 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pravat Mohapatra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pravat Mohapatra
Pravat Mohapatra has 5 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Viropana Drug Private Limited and Laetitia Finserv Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Laetitia Finserv Private Limited at ₹0.67 Cr (FY 2022).
Pravat Mohapatra is associated with 2 companies as Director and Additional Director, including Laetitia Finserv Private Limited (₹0.67 Cr), Viropana Drug Private Limited.
Pravat Mohapatra has expertise in General Business.
Pravat Mohapatra has 5 years in corporate governance.
By reported revenue, the largest current company of Pravat Mohapatra is Laetitia Finserv Private Limited, with revenue of ₹0.67 Cr (FY 2022).
Pravat Mohapatra currently holds positions at 2 companies: Laetitia Finserv Private Limited (₹0.67 Cr), Viropana Drug Private Limited.